Companies › Boulder Care
1 active drug program in 35 registered trials: 20 Phase 4, 7 Phase 2, 5 Phase 3, 3 Phase 1; Neurology, Oncology, Other, Psychiatry; next expected readout Aug 2027.
Open in Phaseline: competitors, likelihood bands and readouts Company report
| Drug | Target | Highest phase | Conditions | Next expected readout |
|---|---|---|---|---|
| Buprenorphine Mu opioid receptor agonist; Kappa opioid receptor agonist | OPRM1, OPRK1 | Phase 1 | Opioid Use Disorder; Postoperative Pain; Pain, Postoperative; Acute Postoperative Pain … | Aug 2027 |
| Registry id | Drug | Phase | Conditions | Area | Expected readout |
|---|---|---|---|---|---|
| NCT06742554 | Buprenorphine | Phase 4 | Postoperative Pain | Other | Apr 2025 |
| NCT04408313 | Buprenorphine | Phase 2 | Opioid-use Disorder | Psychiatry | May 2026 |
| NCT05824832 | Buprenorphine | Phase 4 | Pain, Postoperative | Other | Jun 2026 |
| NCT07524738 | Buprenorphine | Phase 3 | Opioid Use Disorder | Psychiatry | Jul 2026 |
| NCT07439549 | Buprenorphine | Phase 4 | Opioid Use Disorder | Psychiatry | Sep 2026 |
| NCT07439549 | Buprenorphine | Phase 4 | Opioid Use Disorder | Psychiatry | Sep 2026 |
| NCT06051890 | Buprenorphine | Phase 4 | Opioid Use Disorder | Psychiatry | Dec 2026 |
| NCT05778591 | Buprenorphine | Phase 2 | Schizophrenia | Psychiatry | Dec 2026 |
| NCT07430345 | Buprenorphine | Phase 1 | Fracture | Other | Dec 2026 |
| NCT05589181 | Buprenorphine | Phase 3 | Opioid Use Disorder | Psychiatry | Dec 2026 |
| NCT06379984 | Buprenorphine | Phase 2 | Opioid Use Disorder | Psychiatry | Dec 2026 |
| NCT04464980 | Buprenorphine | Phase 2 | Opioid Use Disorder (OUD) | Psychiatry | Dec 2026 |
| NCT04464980 | Buprenorphine | Phase 2 | Opioid Use Disorder (OUD) | Psychiatry | Dec 2026 |
| NCT06880718 | Buprenorphine | Phase 4 | Opioid Use Disorder | Psychiatry | Jan 2027 |
| NCT06880718 | Buprenorphine | Phase 4 | Opioid Use Disorder | Psychiatry | Jan 2027 |
| NCT03646058 | Buprenorphine | Phase 3 | Suicidal Ideation | Psychiatry | Jan 2027 |
| NCT06441604 | Buprenorphine | Phase 2 | Opioid Use Disorder | Psychiatry | Jan 2027 |
| NCT07176351 | Buprenorphine | Phase 4 | Opioid Use Disorder | Psychiatry | Feb 2027 |
| NCT06949826 | Buprenorphine | Phase 4 | Pain, Postoperative | Psychiatry | Mar 2027 |
| NCT07434427 | Buprenorphine | Phase 4 | Acute Postoperative Pain | Neurology | May 2027 |
| NCT06316830 | Buprenorphine | Phase 2 | Opioid Use Disorder | Psychiatry | Aug 2027 |
| NCT07169409 | Buprenorphine | Phase 1 | Opioid Use Disorder | Psychiatry | Aug 2027 |
| NCT06494904 | Buprenorphine | Phase 3 | Opioid Use Disorder | Psychiatry | Sep 2027 |
| NCT05988710 | Buprenorphine | Phase 4 | Analgesia | Psychiatry | Jan 2028 |
| NCT05988710 | Buprenorphine | Phase 4 | Analgesia | Psychiatry | Jan 2028 |
| NCT05988710 | Buprenorphine | Phase 4 | Analgesia | Psychiatry | Jan 2028 |
| NCT06442566 | Buprenorphine | Phase 1 | Opioid Withdrawal | Psychiatry | Mar 2028 |
| NCT07786012 | Buprenorphine | Phase 4 | Cesarean Delivery | Other | Aug 2028 |
| NCT04375033 | Buprenorphine | Phase 4 | Opioid Use Disorder | Psychiatry | Sep 2028 |
| NCT04375033 | Buprenorphine | Phase 4 | Opioid Use Disorder | Psychiatry | Sep 2028 |
| NCT06323824 | Buprenorphine | Phase 4 | Opioid Use Disorder | Psychiatry | Dec 2028 |
| NCT06306443 | Buprenorphine | Phase 3 | Opioid Use Disorder | Psychiatry | Jan 2029 |
| NCT06574009 | Buprenorphine | Phase 4 | Chronic Pain | Oncology | Apr 2029 |
| NCT04811014 | Buprenorphine | Phase 4 | Opioid-use Disorder | Psychiatry | Aug 2030 |
| NCT07485335 | Buprenorphine | Phase 4 | Opioid Use Disorder | Psychiatry | Sep 2030 |
Trevi Therapeutics Currax Pharmaceuticals AgelessRx ReacX Pharmaceuticals Akyso Therapeutics Inventage Lab. Adneuris Therapeutics Alkermes Shionogi Ensysce Biosciences
Programs group the company's trials by drug; the target and mechanism come from Open Targets and ChEMBL via Open Targets; expected readouts are Phaseline's estimate from the registry's primary completion date. Facts from the registries only; the approval likelihood, shown as a band with its track record, is in the app.